Abstract: Three new iminophosphines containing pinacol-derived boronate esters have been prepared and ligated to dichloridoplatinum(II) fragments. All compounds have been characterized fully, including an X-ray diffraction study carried out for the platinum complex 8, which is derived from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline.
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Introduction
Interest in boron pharmaceuticals has rapidly grown in recent years as researchers continue to discover new and remarkable applications for these interesting small molecules. 1 For instance, α-aminoboronic acids are wellrecognized as being a unique class of potent enzyme inhibitors with the boropeptide Velcade ® being the first boron-containing small molecule to be approved by the FDA for the treatment of multiple myeloma. 2 The bioactivity associated with small molecule boron compounds is believed to arise from the electrophilic nature of the three-coordinate boron atom, which contains an empty p-type orbital. The boron atom can readily form dative Lewis acid-base bonds with nucleophiles (i.e. hydroxyl group in serine, bases in DNA, etc) and transform from a neutral trigonal three-coordinate species to a four-coordinate tetrahedral adduct. This dative bonding interaction, which can provide great stability, can also be reversible, unlike the covalent bonds generated when using organic 'suicide inhibitors' and differentiates small molecule boron compounds from traditional pharmaceuticals.
Although there is presently a considerable amount of research focused on designing new organic compounds incorporating boron for potential therapeutic use, 1-8 much less studied are transition metal complexes containing this remarkable element for possible applications in medicinal chemistry. One area where metal-boron chemistry has attracted considerable attention is in the development of novel anticancer agents. [9] [10] [11] [12] [13] Indeed,
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although cisplatin (cis-PtCl2(NH3)2) is a well-known antineoplastic agent, 14
severe side-effects limit its use in cancer therapy and new strategies for designing more efficacious metal anticancer compounds are constantly being investigated. Rendina and co-workers have been instrumental in this area and have been examining terpyridineplatinum(II) derivatives containing either carborane (Chart 1, I) or boronic acid [RB(OH)2] appendages (Chart 1, II). 9
Platinum compounds containing BODIPY groups have also been examined by Weissleder and co-workers for high-resolution in vivo cancer imaging. 10 Other metals are also being examined for their potential bioactivities and a considerable body of work has appeared recently on ferrocene-based prodrugs containing boron (Chart 1, III). 11 More relevant to this present study, however, is a report by Trivedi and co-workers on the in vitro anticancer evaluation on a series of iminopyridinepalladium(II) complexes bearing sugar-boronate esters (Chart 1, IV). 12 As part of our program developing new metal-boron complexes with potential bioactivities, 13 we now disclose our findings on the synthesis and characterization of a small family of iminophosphineplatinum(II) compounds and their cytotoxic properties against two glioma cell lines using the MTT method.
D r a f t Chart 1. Bioactive metal complexes bearing boron groups.
Experimental

Materials and methods
Reagents and solvents used were obtained from Sigma-Aldrich. [PtCl2(η 2 -coe)]2 (coe = cis-cyclooctene) 15 and N-(2-(diphenylphosphino) benzylidene)aniline (1) 16 were prepared as previously reported. Nuclear magnetic resonance (NMR) spectra were recorded on a JEOL JNM-GSX400 This ligand was used as is to make the corresponding platinum complex.
Synthesis of 5
To a stirred toluene (5 mL 
Synthesis of 6
To a stirred toluene (3 mL) suspension of [PtCl2(η 2 -coe)]2 (100 mg, 0.13 mmol)
was added a toluene (1 mL) solution of N-(2-(diphenylphosphino)benzylidene)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (134 mg, 0.27 mmol).
The reaction was allowed to proceed at RT for 2 h, at which point a yellow precipitate was collected by suction filtration and washed with hexane (5 mL 
Synthesis of 7
To a stirred toluene ( The reaction was allowed to proceed at RT for 2 h, at which point a yellow precipitate was collected by suction filtration and washed with hexane (5 mL).
The precipitate was recrystallized from CH2Cl2 (5 mL) and hexane (5 mL 
Synthesis of 8
Stability testing of platinum compounds
In a NMR tube, compounds 5-8 were dissolved in dimethylformamide (1 mL) and analyzed by 31 P{ 1 H} and 11 B NMR spectroscopy. The solutions were stored at 37 o C for 2 d at which point the compounds were reanalyzed by multinuclear NMR spectroscopy.
X-ray crystallography
Crystals of 8 were grown from a saturated acetone solution stored at 5 °C.
Single crystals were coated with Paratone-N oil, mounted using a polyimide MicroMount and frozen in the cold nitrogen stream of the goniometer. A hemisphere of data was collected on a Bruker AXS P4/SMART 1000 diffractometer using ω and φ scans with a scan width of 0.3 o and 30 s exposure times. The detector distance was 5 cm. The data were reduced (SAINT) 17 and corrected for absorption (SADABS). 18 The structure was solved by direct methods and refined by full-matrix least squares on F 2 (SHELXTL). 19 All nonhydrogen atoms were refined using anisotropic displacement parameters.
Hydrogen atoms were included in calculated positions and refined using a riding model.
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Cell cultures
Human glioma cells Hs683 and T98G were cultured in an incubator at 37 °C and 5% CO2 in DMEM supplemented with 10% FBS (foetal bovine serum) and antibiotics (Thermo Fisher Scientific) and have been previously characterized. 20 Hs683 cells were originally provided by Dr. Adrian Merlo (Basel, Switzerland) while T98G cells were purchased from American Type Culture Collection (ATCC, #CRL-1690). 
MTT assays
Results and discussion
Chemistry
Compounds 1-4 have been prepared by a simple condensation reaction between the starting commercially-available aniline derivatives and 2-phosphinobenzaldehyde. Reactions were carried out under an inert-D r a f t atmosphere as imines 2-4, containing the electron-withdrawing boronate ester groups Bpin (pin = pinacolato; 1,2-O2C2Me4), were not stable with respect to water and rapidly converted back to the starting materials. Not surprising, no significant change is observed in either the 31 P{ 1 H} or 11 B NMR data upon formation of the corresponding imine. However, a significant shift in the 1 H NMR spectra is observed as the aldehyde resonance at 10.50 ppm is replaced with a signal around 9 ppm for the newly generated imines. The same trend is also observed in the 13 C NMR data as the aldehyde carbon at 191. indicative of a three coordinate boron atom in a CBO2 environment. 23 As late metals such as palladium and platinum are well known to cleave the C-B bond, 24 we carried out a single crystal X-ray diffraction study on 8 to confirm that the boronate ester group remained intact, the molecular structure of which is shown in Figure 1 . Crystallographic data are provided in Unfortunately, tumors infiltrate into regions of the brain that render complete surgical extraction difficult. Although some improvements in the prognosis of GBM patients have been observed using chemotherapeutic agents, such as cisplatin, the search for novel agents to treat GBM is of utmost importance in an effort to improve this combination of cancer treatment. As such, we have examined platinum complexes 5-8 for their cytotoxic properties against two glioma cell lines using the MTT method. The results ( Fig. 2A and B) showed that complexes 6-8 displayed detectable cytotoxic effects in one or both cell glioma cell lines. While complexes 7 and 8 displayed appreciable cytotoxic activity in Hs683 cells alone, complex 6 exhibited the most significant impact in both models amongst the four novel compounds tested. D r a f t Histograms present % Cell Viability ± SEM.
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Complexes 5-8 and cisplatin were also assessed at additional concentrations in both cell lines to assess LC50 values. Results are presented in Table 2 .
Complex 6 displayed the highest cytotoxic activities when compared with the other three complexes and was more cytotoxic than cisplatin in Hs683 cells. Figure 3 . 
Cisplatin did not exhibit TMZ-sensitizing characteristics. This is aligned with a recent report showing that neoadjuvant cisplatin in GBM and anaplastic astrocytoma patients did not provide added benefits versus TMZ alone. 28 In addition, novel complexes 5-8 did not sensitize cells to TMZ in both glioma models investigated.
D r a f t
Conclusions
Three new iminophosphines containing pinacol-derived boronate esters have been synthesized and ligated to dichloridoplatinum(II) fragments. All compounds have been characterized fully, including an X-ray diffraction study which was carried out for the platinum complex 8, which is derived from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline. These three new platinum complexes, along with the non-boron containing control, have been examined for their initial cytotoxic properties against two glioma cell lines using the MTT method. The most promising candidate from this study was complex 6, where the steric bulk of the boronate ester group may impart enhanced cytotoxic activities. Future work in this area will build on this study in an effort to design a more potent series of metal-based boron compounds with enhanced anticancer activity, the results of which will be disclosed in due course.
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